The Wiskott-Aldrich syndrome

Area of Science:

• Genetics
• Immunology
• Dermatology

Background:

• Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder.
• WAS presents with eczema, immunodeficiency, and thrombocytopenia in affected males.
• Females carrying the WAS gene are typically asymptomatic due to X chromosome inactivation.

Purpose of the Study:

• To map the disease locus of Wiskott-Aldrich syndrome (WAS).
• To develop methods for prenatal diagnosis and carrier identification in WAS families.
• To identify WAS as a candidate for gene therapy.

Main Methods:

• Utilized restriction fragment length polymorphisms (RFLPs) for genetic mapping.
• Employed analysis of appropriate families with affected and unaffected males.
• Combined RFLP studies with methylation analysis for carrier identification.

Main Results:

• The WAS locus was successfully mapped to the proximal short arm of the X chromosome (Xp11).
• Prenatal diagnosis of WAS is now feasible using specific RFLP markers.
• All female carriers of the WAS gene were identified through combined RFLP and methylation analysis.

Conclusions:

• The genetic basis of WAS is localized to Xp11, facilitating diagnostic advancements.
• WAS is a strong candidate for gene therapy due to its primary expression in bone marrow-derived cells.
• Further research using yeast artificial chromosomes aims to clone and characterize the WAS gene.